Evaluation of the Biomechanics of Crowding and the Energetic Cost of Endurance Runners Unilateral Transtibial Amputees.
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Apr 25, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the biomechanics, or the way forces work on the body, affect endurance runners who have had a leg amputated below the knee (called a transtibial amputation). The researchers want to understand how using special running blades made of carbon can help these athletes perform better while also considering their comfort and safety. The study will explore how these blades are adjusted for individual runners to ensure they can run efficiently and reduce the risk of injury, especially when there are differences between their healthy and amputated legs.
To participate in this trial, you must be between 18 and 75 years old, weigh less than 110 kg, and have been running with a sports blade for at least three months. You should also have signed a consent form and be part of a social security scheme. However, if your amputation was due to diabetes complications, you have certain chronic health issues, or if you are pregnant or breastfeeding, you won't be eligible. If you join the study, you can expect to contribute to important research that could improve the experience of other runners with similar amputations and help shape better running aids in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female,
- • Weighing less than 110 kg, in accordance with C-blade recommendations,
- • Subjects who have undergone a unilateral transtibial amputation,
- • Have been running with a sports blade for at least 3 months, over several sessions of at least 3 kilometers.
- • Subjects who have signed a written consent form,
- • Subjects affiliated or entitled to a social security scheme.
- Exclusion Criteria:
- • Subjects whose amputation is due to complications related to diabetes or atherosclerosis.
- • Subjects with chronic or central neurological pathologies
- • Subjects with cardiovascular disorders
- • Subjects with alcohol or drug dependency.
- • Pregnant or breast-feeding women
- • Subjects under court protection.
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint étienne, , France
Patients applied
Trial Officials
David HUPIN, MD-PhD
Principal Investigator
CHU SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported